TY - JOUR
T1 - Microscopic detection and genetic characterisation of schistosome eggs within cervicovaginal lavage sediments from cases of female genital schistosomiasis
AU - Stothard, J. Russell
AU - Mainga, Bright
AU - Kumwenda, Dingase
AU - Chisale, Alice
AU - Nchembe, Tereza
AU - Rice, Christine
AU - Atkins, Lilly
AU - Deles, Guillery
AU - Jones, Sam
AU - Cunningham, Lucas J.
AU - Makaula, Peter
AU - Kayuni, Sekeleghe A.
AU - Musaya, Janelisa
N1 - Publisher Copyright:
© The Author(s), 2025. Published by Cambridge University Press.
PY - 2025/8/6
Y1 - 2025/8/6
N2 - Control of female genital schistosomiasis (FGS) has gained significant international attention, driven in part, as a newly appreciated underlying aetiological risk factor for HIV, HPV and cervical dysplasia. Whilst diagnosis and clinical staging of FGS typically relies upon colposcopy, alternative methods of incrimination have grown, particularly upon application of PCR diagnostic assays that detect schistosome DNA within tissue biopsy, genital (self-)swab and/or cervicovaginal lavage (CVL). With regard to the latter, we present novel evidence that microscopy alone of CVL sediments can be sufficient to incriminate FGS and CVL sediment provides an original source of (viable) schistosome eggs and miracidia for later genetic analysis. Upon a pilot examination of 55 adult women from Malawi with previously proven urogenital schistosomiasis by egg-patent urine microscopy, 25.5% (95% CI = 14.7 - 39.0) were found to have schistosome eggs within CVL, with one woman having more than 50 eggs observed. After praziquantel treatments and upon re-examination one year later, the prevalence of egg-patent CVLs reduced to 14.5% (95% CI = 6.5 - 26.7) although the same woman again presented with more than 50 observable eggs. Molecular DNA analysis by real-time PCR of extracted DNA from CVL sediments and CVL hatched miracidia (and eggs) revealed the dominance of Schistosoma haematobium within the samples, noting a fifth with Schistosoma mattheei co-infections and the singular presence of a putative S. haematobium x mattheei hybrid miracidium. Viable schistosome eggs shed from cervicovaginal surfaces likely represent a minor environmental transmission route, thus promoting secure menstrual hygiene management is needed.
AB - Control of female genital schistosomiasis (FGS) has gained significant international attention, driven in part, as a newly appreciated underlying aetiological risk factor for HIV, HPV and cervical dysplasia. Whilst diagnosis and clinical staging of FGS typically relies upon colposcopy, alternative methods of incrimination have grown, particularly upon application of PCR diagnostic assays that detect schistosome DNA within tissue biopsy, genital (self-)swab and/or cervicovaginal lavage (CVL). With regard to the latter, we present novel evidence that microscopy alone of CVL sediments can be sufficient to incriminate FGS and CVL sediment provides an original source of (viable) schistosome eggs and miracidia for later genetic analysis. Upon a pilot examination of 55 adult women from Malawi with previously proven urogenital schistosomiasis by egg-patent urine microscopy, 25.5% (95% CI = 14.7 - 39.0) were found to have schistosome eggs within CVL, with one woman having more than 50 eggs observed. After praziquantel treatments and upon re-examination one year later, the prevalence of egg-patent CVLs reduced to 14.5% (95% CI = 6.5 - 26.7) although the same woman again presented with more than 50 observable eggs. Molecular DNA analysis by real-time PCR of extracted DNA from CVL sediments and CVL hatched miracidia (and eggs) revealed the dominance of Schistosoma haematobium within the samples, noting a fifth with Schistosoma mattheei co-infections and the singular presence of a putative S. haematobium x mattheei hybrid miracidium. Viable schistosome eggs shed from cervicovaginal surfaces likely represent a minor environmental transmission route, thus promoting secure menstrual hygiene management is needed.
KW - colposcopy
KW - Malawi
KW - menstrual hygiene management
KW - Schistosoma haematobium
KW - Schistosoma mattheei
KW - urogenital schistosomiasis
U2 - 10.1017/S0031182025100656
DO - 10.1017/S0031182025100656
M3 - Article
C2 - 40765163
AN - SCOPUS:105013227729
SN - 0031-1820
JO - Parasitology
JF - Parasitology
ER -